354 related articles for article (PubMed ID: 10656463)
1. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
[TBL] [Abstract][Full Text] [Related]
2. In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity.
Neuwelt EA; Brummett RE; Remsen LG; Kroll RA; Pagel MA; McCormick CI; Guitjens S; Muldoon LL
Cancer Res; 1996 Feb; 56(4):706-9. PubMed ID: 8630999
[TBL] [Abstract][Full Text] [Related]
3. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
Neuwelt EA; Gilmer-Knight K; Lacy C; Nicholson HS; Kraemer DF; Doolittle ND; Hornig GW; Muldoon LL
Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
[TBL] [Abstract][Full Text] [Related]
4. Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors.
Doolittle ND; Muldoon LL; Brummett RE; Tyson RM; Lacy C; Bubalo JS; Kraemer DF; Heinrich MC; Henry JA; Neuwelt EA
Clin Cancer Res; 2001 Mar; 7(3):493-500. PubMed ID: 11297239
[TBL] [Abstract][Full Text] [Related]
5. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
6. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.
Neuwelt EA; Brummett RE; Doolittle ND; Muldoon LL; Kroll RA; Pagel MA; Dojan R; Church V; Remsen LG; Bubalo JS
J Pharmacol Exp Ther; 1998 Jul; 286(1):77-84. PubMed ID: 9655844
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
[TBL] [Abstract][Full Text] [Related]
8. Ototoxic protection of sodium thiosulfate: daily vs constant infusion.
Stocks RM; Gould HJ; Bush AJ; Dudney BW; Pousson M; Thompson JW
Otolaryngol Head Neck Surg; 2004 Jul; 131(1):115-9. PubMed ID: 15243567
[TBL] [Abstract][Full Text] [Related]
9. [Effect of sodium thiosulfate on cisplatin-induced ototoxicity].
Lou WH
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):208-10, 255. PubMed ID: 2076324
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies of the ototoxicity of cisplatin and carboplatin].
Delb W; Feilen S; Koch A; Federspil P
Laryngorhinootologie; 1993 Jan; 72(1):24-7. PubMed ID: 8439352
[TBL] [Abstract][Full Text] [Related]
11. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL
Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.
Cappaert NL; Klis SF; Wijbenga J; Smoorenburg GF
Hear Res; 2005 May; 203(1-2):80-7. PubMed ID: 15855032
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.
Neuwelt EA; Pagel MA; Kraemer DF; Peterson DR; Muldoon LL
J Pharmacol Exp Ther; 2004 May; 309(2):594-9. PubMed ID: 14752063
[TBL] [Abstract][Full Text] [Related]
15. [Effect of sodium thiosulfate on the antitumor effect and nephrotoxicity of CDDP in human gastric cancer transplanted in nude mice].
Saito D; Fujii T; Yoshida S; Ohkura H; Oguro Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):379-85. PubMed ID: 2930203
[TBL] [Abstract][Full Text] [Related]
16. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
Muldoon LL; Walker-Rosenfeld SL; Hale C; Purcell SE; Bennett LC; Neuwelt EA
J Pharmacol Exp Ther; 2001 Mar; 296(3):797-805. PubMed ID: 11181909
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
Murphy D; Daniel SJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
[TBL] [Abstract][Full Text] [Related]
18. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.
Thomas Dickey D; Muldoon LL; Kraemer DF; Neuwelt EA
Hear Res; 2004 Jul; 193(1-2):25-30. PubMed ID: 15219317
[TBL] [Abstract][Full Text] [Related]
19. "Two-route chemotherapy" using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice.
Iwamoto Y; Kawano T; Uozumi J; Aoki K; Baba T
Cancer Treat Rep; 1984 Nov; 68(11):1367-73. PubMed ID: 6541970
[TBL] [Abstract][Full Text] [Related]
20. [Two-route chemotherapy using a combination of anticancer agents and antidotes].
Iwamoto Y; Baba T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):766-72. PubMed ID: 4039123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
